@article{66c639aba0674e588e5fc1817c839f1a,
title = "Effect of Anticholinergic Medications on Falls, Fracture Risk, and Bone Mineral Density Over a 10-Year Period",
author = "Fraser, {Lisa Ann} and Adachi, {Jonathan D.} and Leslie, {William D.} and David Goltzman and Robert Josse and Jerilynn Prior and Stephanie Kaiser and Nancy Kreiger and Kovacs, {Christopher S.} and Anastassiades, {Tassos P.} and Alexandra Papaioannou",
note = "Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The Canadian Multicenter Osteoporosis Study is currently funded by the Canadian Institutes of Health Research (CIHR), Amgen, Merck Frosst Canada Ltd, the Dairy Farmers of Canada, Novartis, and Eli Lilly and Company. L-AF has been on the speaker{\textquoteright}s bureau for Amgen. JDA has been on the speaker{\textquoteright}s bureau and consultant for Amgen, Eli Lilly, Merck, Novartis, and Warner Chilcott and has done clinical trials for Amgen, Eli Lilly, Merck, and Novartis. WDL has been on the speaker{\textquoteright}s bureau for Amgen, Eli Lilly, and Novartis and has received research grants from Amgen, Novartis, and Genzyme. CSK has been a consultant and speaker and/or received honoraria from Amgen, Danone, Eli Lilly, Merck, and Novartis. AP has been a consultant and on the speaker{\textquoteright}s bureau for Amgen, Eli Lilly, Merck, Novartis, and Warner Chilcott and has conducted clinical trials for Eli Lilly, Merck, Novartis, and Pfizer. The other authors have no relevant conflicts of interest to declare. ",
year = "2014",
month = aug,
doi = "10.1177/1060028014535363",
language = "English",
volume = "48",
pages = "954--961",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "8",
}